A Computer Tool Reads Brain Scans to Learn About Glioma Genes
Original title: Multiparametric Quantitative MRI With 2.5D Deep Learning for Molecular Classification and Overall Survival Assessment in Adult-Type Diffuse Gliomas.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was a computer tool tested on past scans from people, not a treatment you can get.
The short version
Researchers tested a computer tool that reads brain scans to learn about a brain tumor.
What was studied. Researchers looked back at brain scans and records of adults with diffuse glioma: A glioma whose cells spread out into the brain around it instead of staying in one lump. That is why the edge on a scan is not a clean line. See the glossary at several hospitals. They compared different computer methods, using groups of 409, 300, 119, 310, and 270 people.
What they found. One method, called 2.5D deep learning, did the best job of spotting two gene changes in the tumors. It beat the four other computer methods they tested. Adding its score to the usual patient information gave a better guess about how long people lived, and 27.5% of the people died during the follow up period.
What this means, and what it doesn't
What it could mean: In time, a scan might help doctors learn about a tumor's genes without more surgery. The same score might help doctors talk about what to expect. Right now this is still research, not part of normal care.
What it doesn't mean: This is not a new treatment, and it is not a cure. The tool was tested on scans and records that were already collected, not in a live clinic. It does not change the care you get today. Doctors still test tumor tissue to confirm the gene changes.
Source: PubMed, October 31, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.